Results 251 to 260 of about 149,607 (322)

Selection of DNA Aptamers Against Parathyroid Hormone for Electrochemical Impedimetric Biosensor System Development. [PDF]

Biotechnol Appl Biochem
Didarian R, Bargh S, Gülerman A, Özalp VC, Erel Ö, Yildirim-Tirgil N.   +5 more
europepmc   +1 more source

The predictive value of postoperative intact parathyroid hormone for symptomatic hypocalcemia in older patients with thyroid cancer. [PDF]

Gland Surg
Zheng LL, Chen KH, Liu ZJ, Dai LH, Qin JB, Li YX, Guan WX.   +6 more
europepmc   +1 more source

Hyperparathyroidism after kidney homotransplantation [PDF]

, 1987
Geis, WP, Hammond, WS, Huffer, WE, Popovtzer, MM, Starzl, TE   +4 more
core  

Personalized parathyroid hormone therapy for hypoparathyroidism: Insights from pharmacokinetic-pharmacodynamic modelling. [PDF]

Br J Clin Pharmacol
Visscher M, Schuls-Fouchier M, Berends AMA, Muller Kobold AC, Punt NC, Touw DJ.   +5 more
europepmc   +1 more source

CXCR4 is a response gene for parathyroid hormone which affects osteoblast and osteoclast function in vitro. [PDF]

Bone Joint Res
Larraz-Prieto B, Lind LH, Olesen JB, Azfer A, Hansen MS, Frost M, Jafari A, Ralston SH, Søe K, Alonso N.   +9 more
europepmc   +1 more source

Eiken syndrome with parathyroid hormone resistance due to a novel parathyroid hormone receptor type 1 mutation: clinical features and functional analysis. [PDF]

J Bone Miner Res
Calder AD, Allgrove J, Höppner J, Cheung M, Alexander S, Garagnani L, Thakker R, Jüppner H, Gardella TJ, Holder-Espinasse M.   +9 more
europepmc   +1 more source

Fracture Risk in Patients on Hemodialysis: the Lower the Parathyroid Hormone the Better? [PDF]

Kidney Int Rep
Jadoul MY, Labriola L.
europepmc   +1 more source

Acute toxicological evaluation of bone-targeted parathyroid hormone-related peptide (PTHrP) antagonist to inhibit breast cancer metastases to bone. [PDF]

Toxicol Rep
Ponnapakkam T, Anbalagan M, Stratford RE, Zou B, Blair R, Rowan BG, Gensure R.   +6 more
europepmc   +1 more source